Literature DB >> 28149802

Operative bed recurrence of thyroid cancer: utility of a preoperative needle localization technique.

Oliver S Eng1, Scott B Grant2, Jason Weissler3, Mitchell Simon4, Sudipta Roychowdhury4, Tomer Davidov3, Stanley Z Trooskin3.   

Abstract

BACKGROUND: Surgical management of recurrent disease after total thyroidectomy and/or neck dissection for thyroid carcinoma remains a challenging clinical problem. Reoperation is associated with a significant increase in morbidity. Preoperative needle localization technique for non-palpable breast tumors has recently been extrapolated to head and neck surgery. We report on the use of preoperative ultrasound-guided needle localization for non-palpable recurrent operative bed disease as an intraoperative aid in resection.
METHODS: Patients with thyroid carcinoma were identified from a retrospective database at a tertiary care center from 2011-2014. Inclusion criteria were history of thyroidectomy and/or neck dissection, non-palpable recurrent disease in the resection bed on surveillance, and ultrasound-guided needle localization of recurrent disease before resection. Perioperative data and outcomes were analyzed.
RESULTS: Seventeen patients were identified using the inclusion criteria listed above. Median patient age was 46 years (53% male, 47% female). A total of 23 masses in the previous operative bed were needle-localized successfully with no major long-term sequelae from this technique. The recurrent laryngeal nerve was involved with tumor in six patients. Two patients, in whom the tumor surrounded the nerve circumferentially, experienced recurrent laryngeal nerve injuries. No patients experienced postoperative hypocalcemia. With a routine surveillance and a median follow-up of 558 days, sixteen of the patients remain with no evidence of disease.
CONCLUSIONS: Preoperative ultrasound-guided needle localization of non-palpable recurrent operative bed disease after thyroidectomy and/or neck dissection is a potentially safe method to aid in resection and cure.

Entities:  

Keywords:  Thyroid cancer; needle localization; recurrence; technique

Year:  2016        PMID: 28149802      PMCID: PMC5233840          DOI: 10.21037/gs.2016.12.12

Source DB:  PubMed          Journal:  Gland Surg        ISSN: 2227-684X


  14 in total

Review 1.  Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer.

Authors:  E L Mazzaferri; R T Kloos
Journal:  J Clin Endocrinol Metab       Date:  2001-04       Impact factor: 5.958

2.  Intraoperative needle localization during neck reexploration.

Authors:  Pamela Zimmerman; Monica DaSilva; Roberto Izquierdo; Lisa Cico; Kara Kort; Patricia Numann
Journal:  Am J Surg       Date:  2004-07       Impact factor: 2.565

3.  Preoperative neck ultrasonographic mapping for persistent/recurrent papillary thyroid cancer.

Authors:  Hussam M Binyousef; Ali S Alzahrani; Saif S Al-Sobhi; Suhaibani Hamed S Al; Mohammed A Chaudhari; Hussain M Raef
Journal:  World J Surg       Date:  2004-11       Impact factor: 3.352

4.  Same-day ultrasound guidance in reoperation for locally recurrent papillary thyroid cancer.

Authors:  Kelly L McCoy; John H Yim; Mitchell E Tublin; Lynn A Burmeister; Jennifer B Ogilvie; Sally E Carty
Journal:  Surgery       Date:  2007-12       Impact factor: 3.982

5.  Morbidity following central compartment reoperation for recurrent or persistent thyroid cancer.

Authors:  Michael K Kim; Susan H Mandel; Zubair Baloch; Virginia A Livolsi; Jill E Langer; Liesje Didonato; Stephanie Fish; Randal S Weber
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2004-10

6.  Radio-guided surgery for lymph node recurrences of differentiated thyroid cancer.

Authors:  Massimo Salvatori; Vittoria Rufini; Francesca Reale; Ana Maria Samanes Gajate; Maria Lodovica Maussier; Luca Revelli; Luigi Troncone; Guglielmo Ardito
Journal:  World J Surg       Date:  2003-07       Impact factor: 3.352

7.  Ultrasound-guided needle localization of recurrent paratracheal thyroid cancer.

Authors:  Aaron M Fletcher; Todd W Preston; David M Kuehn; Eve D Clark; Douglas Van Daele; Henry Hoffman
Journal:  Ann Otol Rhinol Laryngol       Date:  2009-07       Impact factor: 1.547

8.  Reoperative surgery for thyroid disease.

Authors:  Jérémie H Lefevre; Christophe Tresallet; Laurence Leenhardt; Christelle Jublanc; Jean-Paul Chigot; Fabrice Menegaux
Journal:  Langenbecks Arch Surg       Date:  2007-06-26       Impact factor: 3.445

9.  Preoperative US-guided hook-needle insertion in recurrent lymph nodes of papillary thyroid cancer: a help for the surgeon.

Authors:  Raphaëlle Duprez; Patrick Lebas; Olivier Saint Marc; Elise Mongeois; Philippe Emy; Patrick Michenet
Journal:  Eur J Radiol       Date:  2008-11-25       Impact factor: 3.528

10.  Reoperative experience with papillary thyroid cancer.

Authors:  Edwin O Onkendi; Travis J McKenzie; Melanie L Richards; David R Farley; Geoffrey B Thompson; Jan L Kasperbauer; Ian D Hay; Clive S Grant
Journal:  World J Surg       Date:  2014-03       Impact factor: 3.352

View more
  1 in total

1.  Periostin silencing suppresses the aggressive phenotype of thyroid carcinoma cells by suppressing the Akt/thyroid stimulating hormone receptor axis.

Authors:  Min Wang; Chunyi Gui; Shenglong Qiu; Jingdong Tang; Zhihai Peng
Journal:  Cytotechnology       Date:  2017-09-30       Impact factor: 2.058

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.